The House's stopgap spending bill includes Medicare extenders; 40 patient advocacy groups oppose the right-to-try legislation that President Donald Trump is supporting; new research finds fetal alcohol syndrome and alcohol-related disorders may be more common than previously thought.
The deadline for Congress to avoid another government shutdown is fast approaching, and the House has passed a stopgap spending bill that includes provisions to fund a number of Medicare extenders. The Medicare extenders include extensions of the 2% urban, 3% rural, and 22.6% super rural ground ambulance add-on payments; the Geographic Practice Cost Indices; and the Medicare-dependent hospital program. The bill also permanently reauthorizes Medicare Advantage Special Needs Plans for vulnerable populations and includes corrections to the Quality Payment Program under the Medicare Access and CHIP Reauthorization Act. The bill is now headed for a Senate vote.
During his State of the Union address, President Donald Trump brought attention to right-to-try legislation and urged Congress to pass legislation. However, 40 patient advocacy groups have written to House leaders and told them they oppose right-to-try legislation on experimental drugs, reported The Hill. The groups are concerned that the legislation won’t actually increase patient access and might do more harm than good by undermining patient protections. However, supporters of the legislation believe it will give terminally ill patients another chance to access a potentially life-saving drug.
New research in JAMA has found that more American children may be suffering from fetal alcohol disorders than previously thought. According to The New York Times, alcohol-related disorders among children can cause issues that hurt a child’s development and learning ability. Some of the ways to diagnose these disorders can be difficult to identify or be attributed to other diagnoses, making it unclear how common alcohol-related disorders are. However, the researchers estimate that these disorders may be at least as common as autism among American children.
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Eliminating Enhanced PTCs Would Have Cascading Economic Impacts, Report Estimates
March 6th 2025Enhanced premium tax credits (PTCs) have made marketplace health insurance more affordable, and eliminating them could have sweeping impacts on consumers and the health care industry, according to a new report.
Read More
Addressing Health Care Disparities Using a Health Plan Quality Measures Index
February 26th 2025The Health Insurance Disparities Index allows stakeholders to assess progress in addressing health care disparities using publicly available, validated, reported health plan quality metrics results.
Read More